Key Takeaways
- • NMS Capital Group ranked No. 14 out of 30 leading private equity firms in the Los Angeles Business Journal's 2026 Top Private Equity Firms list, marking its seventh consecutive year on the ranking.
- • The firm manages a diversified portfolio across business services, infrastructure, energy, insurance, real estate, and technology sectors, with demonstrated strength in energy and infrastructure investments generating significant market appreciation.
- • NMS Capital's portfolio includes 12 acquisitions (Anne Arundel Dermatology, Safety Management Group, and Surfboard among notable holdings) and 2 IPO exits (Bone Biologics and CENTAURUS Technologies), reflecting a mixed control and non-control investment strategy.
- • Founded in 2010 by Trevor M. Saliba as a family office-backed vehicle, NMS has evolved into a globally focused private equity firm with a team of seven professionals managing multi-sector middle-market opportunities.
- • Christopher S. Botosan, Managing Director, highlighted the firm's strategic capital reallocation away from energy and infrastructure appreciation gains toward underweight sectors including insurance and real estate.
Summary
NMS Capital Group has secured recognition on the Los Angeles Business Journal's Top Private Equity Firms list for 2026, advancing to the No. 14 position among 30 ranked firms. This marks the seventh consecutive year the Beverly Hills-based firm has earned inclusion on the prestigious annual ranking, which highlights leading private equity firms headquartered in Los Angeles managing assets ranging from $605 million to $90 billion. The consistent recognition underscores NMS's sustained performance and operational execution within the competitive institutional capital market.
The firm, founded in 2010 by Trevor M. Saliba as a family office-backed investment vehicle, has grown into a diversified private equity platform with global reach. NMS operates across multiple sectors including business services, infrastructure, energy, insurance, real estate, financial services, media, technology, and consumer products manufacturing. Its portfolio encompasses both control and non-control equity investments across the middle market, reflecting a disciplined and strategic approach to opportunity identification and value creation.
NMS Capital's portfolio demonstrates substantive deployment across its mandate, with 12 recorded acquisitions including Anne Arundel Dermatology, Safety Management Group, and Surfboard, alongside two successful IPO exits (Bone Biologics and CENTAURUS Technologies). These transactions illustrate the firm's ability to execute across different exit pathways and value creation timelines. The portfolio currently operates under a seven-person investment team led by Chairman and CEO Trevor M. Saliba.
Recent performance in energy and infrastructure investments has generated material market appreciation, enabling strategic capital reallocation. According to Christopher S. Botosan, Managing Director at NMS Capital Group, the firm is leveraging this portfolio appreciation to refocus capital into underweight sectors such as insurance and real estate. This dynamic capital redeployment reflects active portfolio management and opportunistic sector rotation consistent with institutional best practices during periods of strong performer appreciation. The firm's continued recognition by the Los Angeles Business Journal reflects both its investment strategy consistency and measurable value creation for portfolio companies.
The firm, founded in 2010 by Trevor M. Saliba as a family office-backed investment vehicle, has grown into a diversified private equity platform with global reach. NMS operates across multiple sectors including business services, infrastructure, energy, insurance, real estate, financial services, media, technology, and consumer products manufacturing. Its portfolio encompasses both control and non-control equity investments across the middle market, reflecting a disciplined and strategic approach to opportunity identification and value creation.
NMS Capital's portfolio demonstrates substantive deployment across its mandate, with 12 recorded acquisitions including Anne Arundel Dermatology, Safety Management Group, and Surfboard, alongside two successful IPO exits (Bone Biologics and CENTAURUS Technologies). These transactions illustrate the firm's ability to execute across different exit pathways and value creation timelines. The portfolio currently operates under a seven-person investment team led by Chairman and CEO Trevor M. Saliba.
Recent performance in energy and infrastructure investments has generated material market appreciation, enabling strategic capital reallocation. According to Christopher S. Botosan, Managing Director at NMS Capital Group, the firm is leveraging this portfolio appreciation to refocus capital into underweight sectors such as insurance and real estate. This dynamic capital redeployment reflects active portfolio management and opportunistic sector rotation consistent with institutional best practices during periods of strong performer appreciation. The firm's continued recognition by the Los Angeles Business Journal reflects both its investment strategy consistency and measurable value creation for portfolio companies.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.